Delivery Order SPE2DB24D1034-SPE2DB25FWFQ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays valued at $3,967.95 under a firm fixed price contract type. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a non-set-aside competitive award, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Valtoco is a rescue medication used in acute seizure management, representing the specialized pharmaceutical products that support...
- The Defense Logistics Agency awarded a delivery order valued at $9,124.26 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Department of Defense's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency awarded a delivery order valued at $2,301.07 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, effective July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute seizure management, reflecting the pharmaceutical supply needs of...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.29 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used in emergency seizure management, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $1,129.62. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, valued at $4,518.48 under a firm fixed price contract. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters location in Conshohocken,...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFQ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, valued at $3,388.86 under a firm fixed-price contract. This competitive award, made on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a small-value transaction for a specialized pharmaceutical product. Valtoco is an emergency rescue medication used to treat acute seizures in patients with epilepsy. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. That prime IDC vehicle provides comprehensive global pharmaceutical support across multiple therapeutic domains to military healthcare programs and the Defense Health Agency. The current Valtoco award exemplifies the broad range of specialty medications supported through this framework, demonstrating AmerisourceBergen Drug Corp's role as a critical supplier of emergency and specialized medical commodities within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/9/25 |